This issue of Surgical Oncology Clinics of North America, guest edited by Dr. Mark Krasna, is devoted to Lung Cancer. Dr. Krasna has assembled expert authors to review the following topics: Epidemiology for Lung Cancer; Screening for Lung Cancer; Pathology for Lung Cancer; Treatment of Patients with Oligometastatic Disease for NSCLC; SBRT/Ablative Therapies for NSCLC; Mediastinal Staging for Lung Cancer; VATS Lobectomy for NSCLC; Robotic Lung Resection for NSCLC; Pneumonectomy for NSCLC; Bronchoscopy-Diagnostic and Therapeutic for NSCLC; Neoadjuvant Therapy for Lung Cancer; Molecular/Targeted Therapy for Lung Cancer; Adjuvant Therapy for Stage 1and 2 NSCLC, and more!
Reihe
Sprache
Verlagsort
Zielgruppe
Produkt-Hinweis
Fadenheftung
Gewebe-Einband
Maße
Höhe: 210 mm
Breite: 150 mm
Dicke: 22 mm
Gewicht
ISBN-13
978-0-323-44857-4 (9780323448574)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Corporate Medical Director of Oncology, Clinical Professor of Surgery, Rutgers-RobertWood Johnson Medical School, Meridian Cancer Care, Jersey Shore University MedicalCenter, Neptune, New Jersey
Autor*in
Corporate Medical Director
Clinical Professor of Surgery
Rutgers Robert Wood Johnson Medical School
1. Foreword: Lung Cancer2. Preface: Lung Cancer3. Epidemiology of Lung Cancer4. Classification and Pathology of Lung Cancer5. Screening for Lung Cancer6. Bronchoscopy: Diagnostic and Therapeutic for Non-Small Cell Lung Cancer7. Mediastinal Staging in Non-Small Cell Lung Cancer8. Thoracoscopic Lobectomy for Non-Small Cell Lung Cancer9. Robotic Lung Resection for Non-Small Cell Lung Cancer10. Pneumonectomy for Non-Small Cell Lung Cancer11. Stereotactic Body Radiotherapy and Ablative Therapies for Lung Cancer12. Neoadjuvant Therapy in Non-Small Cell Lung Cancer13. Adjuvant Therapy for Stage I and II Non-Small Cell Lung Cancer14. Targeted Therapy and Immunotherapy for Lung Cancer15. Local Therapy Indications in the Management of Patients with Oligometastatic Non-Small Cell Lung Cancer
